N'-(4-(Diethylamino)benzylidene)-3-(3-nitrophenyl)-1H-pyrazole-5-carbohydrazide

Catalog No. :
ACFIQT872
CAS No. :
302918-45-2
Molecular Formula :
C21H22N6O3
Molecular Weight :
406.45

IUPAC Name:(E)-N'-(4-(diethylamino)benzylidene)-3-(3-nitrophenyl)-1H-pyrazole-5-carbohydrazide

N'-(4-(Diethylamino)benzylidene)-3-(3-nitrophenyl)-1H-pyrazole-5-carbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN'-(4-(Diethylamino)benzylidene)-3-(3-nitrophenyl)-1H-pyrazole-5-carbohydrazide
IUPAC Name(E)-N'-(4-(diethylamino)benzylidene)-3-(3-nitrophenyl)-1H-pyrazole-5-carbohydrazide
MDL No.MFCD01915163
Molecular FormulaC21H22N6O3
Molecular Weight406.45
SMILESO=C(C1=CC(C2=CC=CC([N+]([O-])=O)=C2)=NN1)N/N=C/C3=CC=C(N(CC)CC)C=C3
InChI KeyNADOEIQHRPUNKC-HYARGMPZSA-N
SynonymN'-{(E)-[4-(diethylamino)phenyl]methylidene}-3-(3-nitrophenyl)-1H-pyrazole-5-carbohydrazide;1H-Pyrazole-3-carboxylic acid, 5-(3-nitrophenyl)-, 2-[[4-(diethylamino)phenyl]methylene]hydrazide;N'-(4-(DIETHYLAMINO)BENZYLIDENE)-3-(3-NITROPHENYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE;N'-(4-(DIETHYLAMINO)BENZYLIDENE)-3-(3-NITROPHENYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE
CAS No.302918-45-2

Synthetic Route by SureRoute

1. ACFIQT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFIQT872 route product structure diagram
    ACFIQT872302918-45-2
Inquiry

2. ACFIQT872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNOWB501 route compound structure diagram
    ACNOWB5011557038-82-0 In Stock
  4. Then
  5. ACFIQT872 route product structure diagram
    ACFIQT872302918-45-2
Inquiry

Comments (0)